STOCK TITAN

April 2022 Stock Losers on News, Micro Caps Included

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of , 20 of 20 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest gainers of April 2022 Every stock ranked by its April 2022 gain, with or without news

100

Ranked drops

-69.23%

Largest, GNCA

100.0%

Below baseline, day +5

20.5%

Median deeper below baseline, day +5

Filter and sort
Rows

100 ranked drops in April 2022

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rows are ordered by the move measured when the board was ranked. A percentage recomputed from the session's own closing prices can sit a little above or below its neighbours; the rank is the one the measured move gave the row.

Rank Symbol close to close Session Catalyst Announcement
1 GNCA More than one ranked move this month 2+ ranked moves -69.23% against the close of 04/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Genocea Presents Encouraging Initial Data from GEN-011 Phase 1/2a Trial at AACR 2022

13:05 ET intraday

2 JCSE under $25M today -68.41% against the close of 04/26/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Uplisting / Compliance JE Cleantech Holdings Limited Announces Closing of Initial Public Offering

00:49 ET premarket

3 GNS More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards -59.08% against the close of 04/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Uplisting / Compliance Genius Group Closes Initial Public Offering

14:13 ET intraday

4 ELYM -55.76% against the close of 04/22/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Eliem Provides Update on ETX-810 and ETX-155 Clinical Programs

07:00 ET premarket

5 CCCC -50.57% against the close of 04/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results C4 Therapeutics Presents Clinical Data from Cohort A of the Ongoing Phase 1/2 Clinical Trial of CFT7455, a Novel IKZF1/3 Degrader

13:00 ET intraday

6 PTGX release reads positive -49.95% against the close of 04/25/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Release reads positive, stock fell 49.95% Protagonist Therapeutics Announces Topline Data from Phase 2 IDEAL Study of PN-943 in Ulcerative Colitis

16:25 ET after hours

7 ACCD release reads positive -49.73% against the close of 04/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Release reads positive, stock fell 49.73% Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2022

16:03 ET after hours

8 APTX -49.15% against the close of 04/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Aptinyx Reports Results from Phase 2b Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy

07:00 ET premarket

9 SIOX -48.57% against the close of 04/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Sio Gene Therapies Provides Corporate Update

16:25 ET after hours

10 CELP More than one ranked move this month 2+ ranked moves -47.97% against the close of 04/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Cypress Environmental Partners Reports Fourth Quarter Results

17:26 ET after hours

11 DOGZ under $25M today release reads positive -46.00% against the close of 04/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Release reads positive, stock fell 46.00% Argus Updates Equity Research Report Coverage on Dogness (DOGZ)

09:00 ET premarket

12 RUBY release reads positive -45.56% against the close of 04/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Release reads positive, stock fell 45.56% Rubius Therapeutics Reports Updated Clinical Data at AACR from the Ongoing Monotherapy Phase 1 Arm of the Phase 1/2 Clinical Trial of RTX-240 in Advanced Solid Tumors Demonstrating Single-Agent Activity and Favorable Tolerability

13:00 ET intraday

13 SGLY under $25M today -44.03% against the close of 04/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Crypto & Treasury Singularity Future Technology and Golden Mainland Form Bitcoin Mining Joint-Venture

08:00 ET premarket

14 TDOC -40.15% against the close of 04/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Teladoc Health Reports First Quarter 2022 Results

16:05 ET after hours

15 IO Also on the opposite board this month on both boards -39.48% against the close of 04/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement ION Commences Voluntary Chapter 11 Process with Lender Support and DIP Financing

20:30 ET after hours

16 VAPO -38.98% against the close of 04/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Guidance Change Vapotherm Announces Preliminary Revenue for First Quarter of 2022 and Withdraws 2022 Annual Guidance

16:30 ET after hours

17 BCYC Also on the opposite board this month on both boards -38.69% against the close of 04/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Bicycle Therapeutics Announces Interim BT8009 Phase I Clinical Trial Results at the 2022 AACR Annual Meeting

07:00 ET premarket

18 SLS release reads positive -37.87% against the close of 03/31/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Release reads positive, stock fell 37.87% SELLAS Life Sciences Signs Exclusive License Agreement with GenFleet Therapeutics for Next-Generation, Highly Selective CDK9 Inhibitor

16:08 ET after hours

19 BCRX -37.81% against the close of 04/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results BioCryst Pauses Enrollment in BCX9930 Clinical Trials

09:15 ET premarket

20 MOLN More than one ranked move this month release reads positive 2+ ranked moves -37.37% against the close of 04/26/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Release reads positive, stock fell 37.37% Molecular Partners to Regain Global Rights for MP0310 from Amgen

16:05 ET after hours

21 GNS More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards -36.30% against the close of 04/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Genius Group Closes Its First Day of Trading on the NYSE American

16:30 ET after hours

22 AVDL Also on the opposite board this month on both boards -36.02% against the close of 04/22/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Avadel Pharmaceuticals Announces Interim Data from the Open-Label RESTORE Study at the 2022 American Academy of Neurology Annual Meeting

08:00 ET premarket

23 NFLX -35.12% against the close of 04/19/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Netflix Releases First-Quarter 2022 Financial Results

16:00 ET after hours

24 CELP More than one ranked move this month 2+ ranked moves -34.53% against the close of 04/22/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Cypress Environmental Partners Reports New Lender – Argonaut Private Equity

16:17 ET after hours

25 NSTG -33.63% against the close of 04/12/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings NanoString Technologies Announces Preliminary Revenue for First Quarter of Fiscal Year 2022

16:01 ET after hours

26 GFAI under $25M today More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards -32.54% against the close of 04/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Guardforce AI Announces Pricing of $10.0 Million Registered Direct Offering

09:25 ET premarket

27 HOTH Also on the opposite board this month on both boards -31.43% against the close of 04/11/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Hoth Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

16:21 ET after hours

28 CGNT -31.13% against the close of 04/04/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Cognyte Announces Fourth Quarter and Fiscal Year Ended January 31, 2022 Results

07:00 ET premarket

29 KTRA under $25M today Also on the opposite board this month on both boards -30.71% against the close of 04/11/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Kintara Announces $8.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

08:30 ET premarket

30 GNCA More than one ranked move this month 2+ ranked moves -30.55% against the close of 04/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Genocea Initiates Restructuring and Announces Plan to Explore Strategic Alternatives

16:05 ET after hours

31 WULF -30.08% against the close of 04/11/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution TeraWulf Inc. Announces Proposed Public Offering of Common Stock

17:20 ET after hours

32 ZNTL release reads positive -30.02% against the close of 04/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Release reads positive, stock fell 30.02% Zentalis Pharmaceuticals Announces Positive Initial Clinical Data on ZN-c3, its Wee1 Inhibitor, in Patients with Advanced Ovarian Cancer at AACR

13:00 ET intraday

33 TRKA release reads positive -29.36% against the close of 04/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Release reads positive, stock fell 29.36% Troika Media Group and Southland Conference Announce 2022 Rebrand

12:00 ET intraday

34 RDW -28.66% against the close of 03/31/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Redwire Corporation Reports Full Fiscal Year 2021 Financial Results

16:45 ET after hours

35 PLSE -26.95% against the close of 03/31/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Pulse Biosciences Reports Fourth Quarter & Full Year 2021 Financial Results

16:05 ET after hours

36 BWV -25.81% against the close of 04/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Blue Water Vaccines Inc to Present at World Vaccine Congress Washington 2022

09:56 ET intraday

37 SCYX -25.80% against the close of 04/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results SCYNEXIS Announces Positive Interim Data from Phase 3 FURI and CARES Studies Highlighting Oral Ibrexafungerp's Potency Against Severe Fungal Infections

08:00 ET premarket

38 GWGH Also on the opposite board this month on both boards -25.57% against the close of 04/06/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement GWG Holdings Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)

17:30 ET after hours

39 AIM under $25M today Also on the opposite board this month release reads positive on both boards -25.19% against the close of 04/11/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Release reads positive, stock fell 25.19% AIM ImmunoTech Provides Progress on Advancement of Ampligen® Clinical Development Program for the Treatment of Pancreatic Cancer

07:47 ET premarket

40 MYOV -25.09% against the close of 04/11/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application for MYFEMBREE® for the Management of Moderate to Severe Pain Associated with Endometriosis

00:00 ET premarket

41 LLNW -25.06% against the close of 04/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Limelight Networks Reports Record First Quarter Results

07:30 ET premarket

42 LIAN -23.71% against the close of 04/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement U.S. Food and Drug Administration Approves Camzyos (mavacamten) for the Treatment of Adults with Symptomatic New York Heart Association Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) to Improve Functional Capacity and Symptoms

08:15 ET premarket

43 NCR -23.24% against the close of 04/26/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings NCR Announces First Quarter 2022 Results

16:05 ET after hours

44 NKTR -23.05% against the close of 04/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Nektar and Bristol Myers Squibb Announce Update on Clinical Development Program for Bempegaldesleukin (BEMPEG) in Combination with Opdivo (nivolumab)

16:30 ET after hours

45 WBEV -22.45% against the close of 04/25/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Summer Water named official wine of the Hollywood Bowl and the Governors Ball Music Festival; continues to scale nationally

08:30 ET premarket

46 CTK -22.36% against the close of 04/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings catalyst from a later release the same session CooTek Announces Plan to Implement ADS Ratio Change

16:30 ET after hours

47 CNTX -22.24% against the close of 04/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Context Therapeutics® Announces Encouraging Preclinical Data from Two Programs to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022

07:30 ET premarket

48 IMRA -22.09% against the close of 04/04/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Imara Announces Results of Interim Analyses of Tovinontrine (IMR-687) Phase 2b Clinical Trials in Sickle Cell Disease and Beta-Thalassemia

06:45 ET premarket

49 IMMX -22.01% against the close of 04/04/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement ImmixBio Management Discusses Key Milestones, Drug Development Timelines and the IMMX Advantage at IMMX Milestone Day Event Held on April 5, 2022

09:30 ET intraday

50 AXSM -21.99% against the close of 04/22/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Axsome Therapeutics to Report First Quarter 2022 Financial Results on May 2, 2022

07:00 ET premarket

51 HCA -21.82% against the close of 04/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings HCA Healthcare Reports First Quarter 2022 Results

07:30 ET premarket

52 TGTX -21.81% against the close of 04/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL

08:30 ET premarket

53 FARO -20.94% against the close of 04/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings FARO Announces First Quarter Financial Results

16:05 ET after hours

54 ANGH -20.43% against the close of 04/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Rotana and Anghami Sign Strategic Partnership to Bring Largest Arabic Library Back to Platform

10:57 ET intraday

55 GFAI under $25M today More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards -20.20% against the close of 04/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Uplisting / Compliance Guardforce AI Regains Compliance with Nasdaq Listing Requirements

07:05 ET premarket

56 IRMD -20.08% against the close of 04/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings catalyst from a later release the same session IRADIMED CORPORATION Announces Executive Transition

16:00 ET after hours

57 LIXT Also on the opposite board this month on both boards -19.90% against the close of 04/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution WallachBeth Capital Announces Completion of LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT) $5.8 Million Registered Direct Offering

14:54 ET intraday

58 HLBZ -19.55% against the close of 04/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Helbiz Announces 2021 Financial Results, YoY Revenue Up 190%

21:03 ET after hours

59 MCRI -19.41% against the close of 04/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Monarch Casino & Resort Reports Record First Quarter Financial Results

16:02 ET after hours

60 VALU -19.19% against the close of 04/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Buyback / Dividend VALUE LINE, INC. ANNOUNCES A 13.6% INCREASE IN ITS QUARTERLY CASH DIVIDEND TO $0.25 PER COMMON SHARE; 8TH CONSECUTIVE INCREASE

13:30 ET intraday

61 HSII -19.02% against the close of 04/25/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Heidrick & Struggles Posts Record First Quarter 2022 Results

16:01 ET after hours

62 MIGI under $25M today -18.71% against the close of 04/18/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Crypto & Treasury Mawson Infrastructure Group Inc. Announces March 2022 Bitcoin Self-Mining, Hosting Co-location and Operational Update

09:00 ET premarket

63 RPTX -18.67% against the close of 04/07/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Repare Therapeutics to Present New Clinical and Preclinical Data at the 2022 AACR Annual Meeting

13:00 ET intraday

64 ARTW under $25M today -18.49% against the close of 04/01/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Art's Way Manufacturing Announces 18.9% Increase in Agricultural Products Segment Revenue over Prior Year for First Quarter of Fiscal 2022, 3.9% Increase for Consolidated Operations

13:00 ET intraday

65 DIDI -18.29% against the close of 04/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings catalyst from a later release the same session DiDi Announces Board Change

08:30 ET premarket

66 SPRO -18.28% against the close of 03/31/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Spero Therapeutics Announces Fourth Quarter and Full Year 2021 Operating Results and Provides Business Update

16:05 ET after hours

67 HRTG -18.04% against the close of 04/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Heritage Announces Preliminary First Quarter 2022 Weather Losses

16:30 ET after hours

68 GPS -17.98% against the close of 04/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Gap Inc. Announces Old Navy Leadership Change

16:15 ET after hours

69 GBNH -17.77% against the close of 03/31/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Greenbrook TMS Reports Record Fiscal 2021 Operational and Financial Results

17:05 ET after hours

70 SISI under $25M today -17.73% against the close of 04/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Shineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of US$2.2 Million

08:30 ET premarket

71 SEV More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards -17.19% against the close of 04/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Sono Motors Announces Pricing of Follow-on Offering

01:32 ET premarket

72 NVCN -17.14% against the close of 04/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Neovasc Announces Effective Date of Share Consolidation

16:05 ET after hours

73 IESC -17.07% against the close of 04/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings IES Holdings Reports Fiscal 2022 Second Quarter Results

07:45 ET premarket

74 SLDB -16.98% against the close of 04/26/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Solid Biosciences Announces Updated Corporate Strategy to Develop SGT-001 and SGT-003 Pipeline Programs for Patients with Duchenne Muscular Dystrophy

07:30 ET premarket

75 AA -16.94% against the close of 04/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings 1Q22: Alcoa Posts Strong Quarterly Results Supported by Robust Aluminum Pricing

16:10 ET after hours

76 DNAY -16.90% against the close of 04/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Codex DNA to Showcase Innovative SOLA Enzymatic DNA Synthesis Technology and Automated Benchtop BioXp System at SynBioBeta’s Built with Biology Global Conference

08:03 ET premarket

77 EXTR -16.81% against the close of 04/26/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Extreme Networks Reports Third Quarter Fiscal Year 2022 Financial Results

07:05 ET premarket

78 CLSN -16.72% against the close of 04/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution CELSION CORPORATION ANNOUNCES $7.0 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

08:30 ET premarket

79 COSM -16.67% against the close of 04/11/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Cosmos Holdings Launches Mediterranation, a New Premium Nutritional Supplements Line

09:15 ET premarket

80 GAME -16.67% against the close of 04/14/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Engine Gaming & Media, Inc. Reports Fiscal Second Quarter 2022 Financial Results

16:05 ET after hours

81 ZY -16.59% against the close of 04/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022

16:05 ET after hours

82 CMBM under $25M today -16.58% against the close of 04/13/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Cambium Networks Corporation Announces Preliminary First Quarter 2022 Revenues and Reporting Date

16:01 ET after hours

83 CSTL -16.50% against the close of 04/04/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Castle Biosciences to Acquire AltheaDx

16:05 ET after hours

84 SEV More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards -16.44% against the close of 04/26/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Sono Motors Announces Follow-on Offering

16:10 ET after hours

85 INZY Also on the opposite board this month on both boards -16.34% against the close of 04/11/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Inozyme Pharma Provides Update for Phase 1/2 Clinical Trials in ABCC6 Deficiency and ENPP1 Deficiency

07:30 ET premarket

86 REED under $25M today -16.31% against the close of 03/31/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Reed’s Reports Fourth Quarter and Full Year 2021 Results

16:05 ET after hours

87 RYTM -16.31% against the close of 04/05/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Rhythm Pharmaceuticals Optimizes Design of EMANATE and DAYBREAK Clinical Trials to Advance Setmelanotide for Rare Genetic Diseases of Obesity

08:00 ET premarket

88 MOLN More than one ranked move this month 2+ ranked moves -16.17% against the close of 04/25/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Molecular Partners Provides Update on Ensovibep Following Novartis Quarterly Earnings Call

14:00 ET intraday

89 WEI -16.08% against the close of 04/01/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
No Stated Cause Weidai Comments on Unusual Market Activity

01:41 ET premarket

90 SCPH -16.05% against the close of 04/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement scPharmaceuticals Inc. Announces Resubmission of FUROSCIX® New Drug Application

07:00 ET premarket

91 RILY -15.82% against the close of 04/28/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings B. Riley Financial Reports First Quarter 2022 Results

16:05 ET after hours

92 BLND -15.79% against the close of 03/31/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Blend Announces Fourth Quarter and Full Year 2021 Financial Results

16:15 ET after hours

93 PSTV -15.76% against the close of 04/21/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Plus Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights

16:05 ET after hours

94 SGLB -15.73% against the close of 04/26/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Sigma Labs Reports First Quarter 2022 Financial Results

16:01 ET after hours

95 XRX -15.67% against the close of 04/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Xerox Releases First-Quarter Results

06:30 ET premarket

96 ENJY -15.67% against the close of 04/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Enjoy Technology To Report First Quarter 2022 Financial Results on May 11, 2022

16:05 ET after hours

97 CHRA -15.63% against the close of 03/31/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Charah Solutions, Inc. Reports Fourth Quarter and Full Year 2021 Results

22:35 ET after hours

98 NRSN under $25M today -15.55% against the close of 04/08/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement NeuroSense Therapeutics Commences Enrollment and Dosing in its Pharmacokinetic Study of PrimeC for ALS

08:30 ET premarket

99 ALGN -15.47% against the close of 04/27/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Align Technology Announces First Quarter 2022 Financial Results

16:00 ET after hours

100 VERB -15.43% against the close of 04/20/2022 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution VERB Technology Company, Inc. Announces $11.0 Million Registered Direct Offering Priced At-The-Market

08:30 ET premarket

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 251 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Exclude the $5M to $25M band

3 candidate events for this board could not be anchored to a trading session and are not listed.

1 event was left out of this board because the price series changes basis between the baseline close and the measured one, so the two prices do not describe the same shares of the same company and their ratio measures a corporate action, or a change in what the ticker identifies, rather than a move.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In April 2022, the median decliner was 20.5% deeper below its pre-news close five sessions later; the largest catalyst group was Earnings, 39 of the 100 events, at a median of -18.3%.

Close-to-close change on the measured trading session, against the previous close.

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst Events Share of board Median move close to close Median at day +5 Still below the pre-news close at day +5
Earnings 39 39.0% -18.3% -24.2% 100.0% of 39
Other Announcement 19 19.0% -25.1% -29.9% 100.0% of 19
Clinical Trial Results 18 18.0% -33.0% -40.0% 100.0% of 18
Offering / Dilution 9 9.0% Fewer than 10 events in this group, so no figures are shown.
Contract / Partnership 3 3.0% Fewer than 10 events in this group, so no figures are shown.

8 other catalyst types, 12 events: Uplisting / Compliance, M&A / Acquisition, Crypto & Treasury, FDA & Regulatory, Guidance Change, Buyback / Dividend, Leadership Change, No Stated Cause.

How much of the drop held

Horizon Still below the pre-news close close to close Median change since the measured close as a share of the drop
Day +1 100.0% of 100 7.5% deeper below baseline, of 100
Day +5 100.0% of 100 20.5% deeper below baseline, of 100
Month end 98.9% of 91 29.2% deeper below baseline, of 91
Month end falls before day +5 for 23 of these 91 events, so this row is not a later horizon than the one above it. 91 of the 100 events have a month-end close later than the measured session; 8 have it on the measured session itself, and 1 has no month-end close.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside April 2022

Two or more ranked moves this month, each on a different trading day.

SymbolMeasured sessionsLargest drop
GNCA 2Clinical Trial Results, M&A / Acquisition -69.23%
GNS 2Uplisting / Compliance, Other Announcement -59.08%
CELP 2Earnings, Other Announcement -47.97%
MOLN 2Other Announcement, Earnings -37.37%
GFAI 2Offering / Dilution, Uplisting / Compliance -32.54%
SEV 2Offering / Dilution -17.19%

Also fallen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

SymbolMonthsLargest drop
KPTI 2022-03, 2022-02 -39.75%
IMPP 2022-03, 2022-01 -55.05%
AMBA 2022-03, 2022-01 -31.30%
USWS 2022-03, 2022-02 -26.86%
VEON 2022-03, 2022-02 -35.96%
OCGN 2022-03, 2022-02 -26.00%
SLNO 2022-03, 2022-01 -22.81%
GFAIthis month too 2022-02, 2022-01 -29.31%
YMTX 2022-02, 2022-01 -28.81%
RBBN 2022-02, 2022-01 -22.74%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

  • Pre-market40.0%
  • Intraday14.0%
  • After hours46.0%

Volume against normal

  • Under 5x33 events, 34.0%
  • 5x to 20x43 events, 44.3%
  • Over 20x21 events, 21.6%

3 events have too little trading history for a relative volume, and are not in the tiers above.

Industry

  • Pharmaceutical Preparations21 events, 21.0%
  • Biological Products, (no Diagnostic Substances)4 events, 4.0%
  • Surgical & Medical Instruments & Apparatus3 events, 3.0%
  • Finance Services2 events, 2.0%
  • Investment Advice2 events, 2.0%
  • Motor Vehicles & Passenger Car Bodies2 events, 2.0%

24 other industries, 24 events

Industry not known: 42.0%

9 events on this board carry the flag for a move that ran against its own release, too few to say whether the flag predicts anything.

Against March 2022

100 events in the comparable window.

March 2022 median -27.0%, selected from the 11,093 events in that month's eligible pool

April 2022 median -21.9%, 5.1 points shallower than March 2022. April 2022's median is taken over the 100 ranked rows, selected from the 10,777 events in that month's eligible pool.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

  • An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
  • One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
  • A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
  • No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.